← Leaderboards
Arthur Yang
Industrial Science & Technology Network
$4,207,056
Attributed
$4,207,056
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $900K · FY2006–25$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,207,056 · 5
By mechanism
R44$3,477,962 · 2
R43$729,094 · 3
Top collaborators
No co-investigators on record.
Most similar at Industrial Science & Technology Network
Same institution · by research overlap
- Roman Domszy$2,115,000
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsDrug Delivery SystemsSurfacePolymersLensDesignEyedropsToxic EffectTechnologyPrototypeContact LensesDrug ControlsAffectAmericanOphthalmic DrugDropsOpticsSiliconesCommercializationBiological AvailabilityHourDosageMarketingClinical Trials
Grant awards (9)
Drug delivery platform for ocular allergy therapy$900,003
R44 · FY2025 · EY · contact PI
Drug delivery platform for ocular allergy therapy$900,003
R44 · FY2024 · EY · contact PI
Drug delivery platform for ocular allergy therapy$300,000
R43 · FY2022 · EY · contact PI
Ophthalmic drug delivery using a multi-layer contact lens design that enables targeting, constant-rate release and failure protection$168,912
R44 · FY2020 · EY · contact PI
Ophthalmic drug delivery using a multi-layer contact lens design that enables targeting, constant-rate release and failure protection$754,259
R44 · FY2019 · EY · contact PI
Ophthalmic drug delivery using a multi-layer contact lens design that enables targeting, constant-rate release and failure protection$754,785
R44 · FY2018 · EY · contact PI
Ophthalmic drug delivery using a multi-layer contact lens design that enables targeting, constant-rate release and failure protection$225,000
R43 · FY2016 · EY · contact PI
Ophthalmic drug delivery using a multi-layer contact lens design that enables targeting, constant-rate release and failure protection$30,750
R43 · FY2016 · EY · contact PI
Nanopore Enhanced Lipase Bioreactors$173,344
R43 · FY2006 · GM · contact PI